PM20D1-DERIVED TREATMENT DECREASES AMYLOID PATHOLOGY AND IMPROVES COGNITIVE PERFORMANCE IN C.ELEGANS AND MOUSE MODELS OF ALZHEIMER´S DISEASE (ID 2248)

Presenter
Authors
Gallery Display
Onsite Oral and Gallery PDF
Audio MP3

Audio MP3

Hide

Previous ePoster
SIRT6 ROLES IN PROTECTING THE BRAIN FROM NEURODEGENERATION (ID 2247)

Next ePosters
A NOVEL MODEL OF CEREBRAL SMALL VESSEL DISEASE WITH WHITE MATTER HYPERINTENSITIES AND PERIPHERAL OXIDATIVE STRESS USING THE SABRA RATS (ID 2387)
CLASSIFICATION OF DIFFERENT CAUSES OF DEMENTIA USING DEEP LEARNING TECHNIQUES ON EEG MEASUREMENTS (ID 2361)
CORTICAL NETWORK MODULARITY CHANGES ALONG THE COURSE OF FRONTOTEMPORAL AND ALZHEIMER’S DEMENTING DISEASES (ID 2363)
RELATIONSHIP BETWEEN CSF ABETA42/40 AND [18F]FLUTEMETAMOL PET-DERIVED CENTILOID UNITS IN SUBJECTIVE COGNITIVE DECLINE AND MILD COGNITIVE IMPAIRMENT (ID 2364)
EVALUATING THE SENSITIVITY OF CENTILOID QUANTIFICATION TO PIPELINE DESIGN (ID 2365)
REACTIVE ASTROCYTES AS IMAGED WITH 11C-DED IN PATIENTS WITH DIFFERENT DEMENTIA DISORDERS (ID 2366)
DETECTION OF TAU ACCUMULATION IN AMYLOID POSITIVE PRECLINICAL AND EARLY AD USING [18F]RO-948, [18F]MK-6240, [18F]GTP1, AND [18F]FLORTAUCIPIR TAU PET TRACERS (ID 2410)
SMALL VESSELS-BIG PROBLEMS IN ALZHEIMER’S DISEASE (ID 2411)
COMPARISON OF STRUCTURAL AND METABOLIC BIOMARKERS FOR BRAIN AGE PREDICTION USING MACHINE LEARNING (ID 2314)
EEG ABNORMALITIES IN PATIENTS WITH DELIRIUM AS A PREDICTIVE BIOMARKER OF DEMENTIA WITH LEWY BODIES (ID 2315)